Tower Research Capital LLC (Trc) Lian Bio Transaction History

Tower Research Capital LLC (Trc)

  • $4.07 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.85 $1,571 - $2,502
878 New
878 $2,000
Q4 2022

Feb 10, 2023
SELL
$1.14 - $2.11 $13,969 - $25,855
-12,254 Reduced 58.99%
8,519 $14,000
Q3 2022

Nov 10, 2022
BUY
$1.87 - $3.0 $36,681 - $58,848
19,616 Added 1695.42%
20,773 $41,000
Q2 2022

Aug 15, 2022
SELL
$2.15 - $6.01 $10,203 - $28,523
-4,746 Reduced 80.4%
1,157 $3,000
Q1 2022

May 12, 2022
BUY
$2.8 - $6.21 $16,528 - $36,657
5,903 New
5,903 $22,000

Others Institutions Holding LIAN

# of Institutions
4
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email